Paper Review Records
All Paper Review Records
19 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
51
days
Updates in Evidence‐Based Decision Making for Upfront Surgical Interventions in Paediatric Lymphoma
AuthorsLiam Vierboom; Amos H. P. Loh
Affiliations1. KK Women's and Children's Hospital Singapore Singapore
26
days
What Does It Really Mean to Say That a Patient With a Hematologic Malignancy Is “Cured”?
AuthorsFortunato Morabito; Ernesto Vigna; Enrica Antonia Martino; Massimo Gentile
Affiliations1. AIL Sezione di Cosenza cosenza Italy; 2. Hematology Unit, Department of Onco‐Hematology AO of Cosenza Cosenza Italy; 3. Department of Pharmacy, Health and Nutritional Science University of Calabria Rende Italy
26
days
Cardiovascular Safety Across Leading BTK Inhibitors in Relapsed/Refractory CLL : Results of a Network Meta‐Analysis
AuthorsStefano Molica; Diana Giannarelli; David Allsup
Affiliations1. Hull York Medical School University of Hull Hull UK; 2. Biostatistics Unit Scientific Directorate Fondazione Policlinico Universitario Agostino Gemelli IRCCS Rome Italy; 3. Centre for Biomedicine Hull York Medical School Hull UK
28
days
Delayed Diagnosis of Adult Haemoglobinopathies: An Exploratory Retrospective Study of Diagnostic Trajectories and a Preliminary Clinical Suspicion Framework
AuthorsSophia Delicou; Aikaterini Poulaki; Iliana Mani; Christos Savvidis; Aikaterini Xydaki; Maria Moraki; Constantina Aggeli; Ioannis Ilias; John Koskinas
Affiliations1. Thalassaemia and Sickle Cell Unit, Expertise Centre of Haemoglobinopathies and Their Complications General Hospital of Athens Hippokrateio Athens Greece; 2. Second Department of Internal Medicine, Expertise Centre of Haemoglobinopathies and Their Complications General Hospital of Athens Hippokrateio Athens Greece; 3. Endocrinology Unit, Expertise Centre of Haemoglobinopathies and Their Complications General Hospital of Athens Hippokrateio Athens Greece; 4. First Department of Cardiology, Expertise Centre of Haemoglobinopathies and Their Complications General Hospital of Athens Hippokrateio, National and Kapodistrian University of Athens Athens Greece
128
days
Development of Chimeric Antigen Receptor‐Modified NK Cells for the Immunotherapy of Adult T‐Cell Leukemia/Lymphoma
AuthorsYuichiro Uchida; Seigo Tateo; Masahiro Wakao; Hiroyuki Shinchi; Hayate Sawayama; Akira Fukumoto; Makoto Yoshimitsu; Yasuo Suda
Affiliations1. SUDx‐Biotec Corporation Kagoshima Japan; 2. Graduate School of Science and Engineering Kagoshima University Kagoshima Japan; 3. Department of Hematology and Rheumatology, Graduate School of Medical and Dental Sciences Kagoshima University Kagoshima Japan
63
days
Efficacy and Safety of Bendamustine Versus Fludarabine and Cyclophosphamide as Lymphodepleting Regimens for CAR ‐T Therapy in Hematological Malignancies: A Systematic Review and Meta‐Analysis
AuthorsAkihiro Miyashita; Magda Sofía Jiménez Castellanos; Thomas Rodgers
Affiliations1. Department of Internal Medicine University of Hawaiʻi John A. Burns School of Medicine Honolulu Hawaii USA; 2. Facultad de Medicina C‐II “Dr. Manuel Velasco Suárez” Universidad Autónoma de Chiapas, Tuxtla Gutiérrez Chiapas Mexico; 3. Department of Hematology and Medical Oncology Hawaii Pacific Health Honolulu Hawaii USA; 4. Department of Veterans Affairs Raleigh North Carolina USA; 5. Department of Medicine University of Hawaiʻi Honolulu Hawaii USA
26
days
Multiomic Single‐Cell Sequencing Identifies BCR::ABL1 as an Acquired Resistance Mechanism in FLT3+ AML
AuthorsVanessa E. Kennedy; Cheryl A. C. Peretz; Andrew Koh; Elaine Tran; Dalia Dhingra; Saurabh Gulati; Adam Sciambi; Olga Sala‐Torra; Lan Beppu; Jerald P. Radich; Catherine C. Smith
Affiliations1. Department of Medicine Stanford University Stanford California USA; 2. Division of Oncology, Department of Pediatrics University of California San Francisco San Francisco California USA; 3. Division of Hematology/Oncology, Department of Medicine University of California San Francisco San Francisco California USA; 4. Mission Bio San Francisco California USA; 5. Fred Hutchinson Cancer Center Seattle Washington USA
50
days
Evaluation of the Eosin‐5′‐Maleimide Flow Cytometry Test for the Diagnosis of Hereditary Spherocytosis
AuthorsPablo Adrian Biaggioni; Alejandro Ceferino López Romero
Affiliations1. Hematology Department and Teaching Department IACA Laboratorios Bahía Blanca Argentina; 2. Hematology Department IACA Laboratorios Bahía Blanca Argentina
15
days
Minimal Residual Disease as a Biological Trait: Rethinking Disease Persistence in Hematologic Malignancies
AuthorsSantino Caserta; Enrica Antonia Martino; Ernesto Vigna; Mamdouh Skafi; Antonella Bruzzese; Nicola Amodio; Eugenio Lucia; Graziella D'Arrigo; Virginia Olivito; Caterina Labanca; Francesco Mendicino; Maria Eugenia Alvaro; Giovanni Tripepi; Fortunato Morabito; Massimo Gentile
Affiliations1. Hematology Unit, Department of Onco‐Hematology, AO of Cosenza Cosenza Italy; 2. Emergency and Internal Medicine Department Saint Joseph Hospital East Jerusalem Palestine; 3. Department of Experimental and Clinical Medicine University of Catanzaro Catanzaro Italy; 4. Istituto di Fisiologia Clinica del CNR di Reggio Calabria, Consiglio Nazionale Delle Ricerche Reggio Calabria Italy; 5. AIL Sezione di Cosenza Cosenza Italy; 6. Department of Pharmacy, Health and Nutritional Science University of Calabria Rende Italy
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days